Literature DB >> 6441524

Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome.

P E Rose, S M Enayat, R Sunderland, P E Short, C E Williams, F G Hill.   

Abstract

Factor VIII related activities and factor VIII related antigen multimeric analysis have been assessed in two sporadic and eleven epidemic cases of haemolytic uraemic syndrome. In all patients factor VIII related antigen was raised and had an abnormal multimer pattern at presentation. The return to normal of factor VIII related antigen values and multimeric analysis patterns paralleled clinical improvement and, therefore, may be useful in monitoring patients with haemolytic uraemic syndrome. We postulate that endothelial cell damage releases the abnormal high molecular weight factor VIII related antigen multimers and that this may cause platelet agglutination in vivo.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441524      PMCID: PMC1628917          DOI: 10.1136/adc.59.12.1135

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

1.  [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia].

Authors:  C GASSER; E GAUTIER; A STECK; R E SIEBENMANN; R OECHSLIN
Journal:  Schweiz Med Wochenschr       Date:  1955-09-20

2.  Preservation of platelet receptors for platelet aggregating factor/von Willebrand factor by air drying, freezing, or lyophilization: new stable platelet preparations for von Willebrand factor assays.

Authors:  K M Brinkhous; M S Read
Journal:  Thromb Res       Date:  1978-10       Impact factor: 3.944

Review 3.  The von Willebrand syndrome.

Authors:  A L Bloom
Journal:  Semin Hematol       Date:  1980-10       Impact factor: 3.851

4.  The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome.

Authors:  A C Appiani; A Edefonti; A Bettinelli; M M Cossu; M L Paracchini; E Rossi
Journal:  Clin Nephrol       Date:  1982-04       Impact factor: 0.975

5.  Effects of platelet inhibitors on the platelet aggregation induced by plasma from patients with thrombotic thrombocytopenic purpura.

Authors:  E C Lian; N Savaraj
Journal:  Blood       Date:  1981-08       Impact factor: 22.113

6.  Prostacyclin deficiency in haemolytic-uraemic syndrome.

Authors:  J Webster; A J Rees; P J Lewis; C N Hensby
Journal:  Br Med J       Date:  1980-07-26

7.  Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.

Authors:  T Fujimoto; S Ohara; J Hawiger
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

8.  Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?

Authors:  G Remuzzi; R Misiani; D Marchesi; M Livio; G Mecca; G de Gaetano; M B Donati
Journal:  Lancet       Date:  1978-10-21       Impact factor: 79.321

9.  The complex multimeric composition of factor VIII/von Willebrand factor.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  Blood       Date:  1981-06       Impact factor: 22.113

10.  Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseases.

Authors:  J R Hoyer; A F Michael; L W Hoyer
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

View more
  9 in total

Review 1.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Circulating adhesion molecules ICAM-1, E-selectin, and von Willebrand factor in Henoch-Schönlein purpura.

Authors:  O Söylemezoglu; N Sultan; T Gursel; N Buyan; E Hasanoglu
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

Review 3.  Pathogenesis of the hemolytic uremic syndromes: current concepts.

Authors:  B S Kaplan; V V Vedaranayanan
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

Review 4.  Causes of the haemolytic uraemic syndrome.

Authors:  J Kavi; R Wise
Journal:  BMJ       Date:  1989-01-14

5.  Classification of haemolytic uraemic syndrome.

Authors:  R P Cooke; P E Rose
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

Review 6.  Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes.

Authors:  B S Kaplan; T G Cleary; T G Obrig
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

Review 7.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

Review 8.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

9.  von Willebrand factor antigen compared with other factors in vasculitic syndromes.

Authors:  E Ateş; A Bakkaloğlu; U Saatçi; O Söylemezoğlu
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.